메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 59, Issue 8, 2015, Pages 4616-4624
Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells
Author keywords

[No Author keywords available]
Indexed keywords

AMOXICILLIN; CEFTRIAXONE; DAPTOMYCIN; DOXYCYCLINE; GEMIFLOXACIN; METRONIDAZOLE; MITOMYCIN; NITROREDUCTASE; SPECTINOMYCIN; TEIXOBACTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;
EID: 84939824523     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00864-15     Document Type: Article
Times cited : (122)
References (62)
  • 2
    • 77955628762 scopus 로고    scopus 로고
    • Persister cells
    • Lewis K. 2010. Persister cells. Annu Rev Microbiol 64:357-372. http://dx.doi.org/10.1146/annurev.micro.112408.134306.
    • (2010) Annu Rev Microbiol , vol.64 , pp. 357-372
    • Lewis, K.1
  • 4
    • 0036840348 scopus 로고    scopus 로고
    • Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms
    • Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. 2002. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 70:6339-6345. http://dx.doi.org/10.1128/IAI.70.11.6339-6345.2002.
    • (2002) Infect Immun , vol.70 , pp. 6339-6345
    • Leid, J.G.1    Shirtliff, M.E.2    Costerton, J.W.3    Stoodley, A.P.4
  • 5
    • 1342304447 scopus 로고    scopus 로고
    • Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system
    • Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6:269-275. http://dx.doi.org/10.1046/j.1462-5822.2004.00367.x.
    • (2004) Cell Microbiol , vol.6 , pp. 269-275
    • Vuong, C.1    Voyich, J.M.2    Fischer, E.R.3    Braughton, K.R.4    Whitney, A.R.5    DeLeo, F.R.6    Otto, M.7
  • 6
    • 77957947243 scopus 로고    scopus 로고
    • Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis
    • Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191-6199. http://dx.doi.org/10.1128/JB.01651-09.
    • (2010) J Bacteriol , vol.192 , pp. 6191-6199
    • Mulcahy, L.R.1    Burns, J.L.2    Lory, S.3    Lewis, K.4
  • 7
    • 73849102829 scopus 로고    scopus 로고
    • Patients with long-term oral carriage harbor high-persister mutants of Candida albicans
    • Lafleur MD, Qi Q, Lewis K. 2010. Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54:39-44. http://dx.doi.org/10.1128/AAC.00860-09.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 39-44
    • Lafleur, M.D.1    Qi, Q.2    Lewis, K.3
  • 8
    • 84892181925 scopus 로고    scopus 로고
    • Internalization of Salmonella by macrophages induces formation of nonreplicating persisters
    • Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. 2014. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343:204-208. http://dx.doi.org/10.1126/science.1244705.
    • (2014) Science , vol.343 , pp. 204-208
    • Helaine, S.1    Cheverton, A.M.2    Watson, K.G.3    Faure, L.M.4    Matthews, S.A.5    Holden, D.W.6
  • 11
    • 0035849985 scopus 로고    scopus 로고
    • Lyme disease
    • Steere AC. 2001. Lyme disease. N Engl J Med 345:115-125. http://dx.doi.org/10.1056/NEJM200107123450207.
    • (2001) N Engl J Med , vol.345 , pp. 115-125
    • Steere, A.C.1
  • 12
    • 84864812174 scopus 로고    scopus 로고
    • In the clinic. Lyme disease
    • Hu LT. 2012. In the clinic. Lyme disease. Ann Intern Med 157:ITC2-2-ITC2-16. http://dx.doi.org/10.7326/0003-4819-157-3-201208070-01002.
    • (2012) Ann Intern Med , vol.157 , pp. ITC22-ITC216
    • Hu, L.T.1
  • 13
    • 42949175035 scopus 로고    scopus 로고
    • Lyme arthritis: Pathogenesis, clinical presentation, and management
    • Puius YA, Kalish RA. 2008. Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis Clin North Am 22:289-300. http://dx.doi.org/10.1016/j.idc.2007.12.014.
    • (2008) Infect Dis Clin North Am , vol.22 , pp. 289-300
    • Puius, Y.A.1    Kalish, R.A.2
  • 14
    • 0023609768 scopus 로고
    • The clinical evolution of Lyme arthritis
    • Steere AC, Schoen RT, Taylor E. 1987. The clinical evolution of Lyme arthritis. Ann Intern Med 107:725-731. http://dx.doi.org/10.7326/0003-4819-107-5-725.
    • (1987) Ann Intern Med , vol.107 , pp. 725-731
    • Steere, A.C.1    Schoen, R.T.2    Taylor, E.3
  • 15
    • 33750334242 scopus 로고    scopus 로고
    • Therapy for Lyme arthritis: Strategies for the treatment of antibiotic-refractory arthritis
    • Steere AC, Angelis SM. 2006. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54:3079-3086. http://dx.doi.org/10.1002/art.22131.
    • (2006) Arthritis Rheum , vol.54 , pp. 3079-3086
    • Steere, A.C.1    Angelis, S.M.2
  • 17
    • 4644243233 scopus 로고    scopus 로고
    • Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses
    • Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E. 2004. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 72:5759-5767. http://dx.doi.org/10.1128/IAI.72.10.5759-5767.2004.
    • (2004) Infect Immun , vol.72 , pp. 5759-5767
    • Liang, F.T.1    Yan, J.2    Mbow, M.L.3    Sviat, S.L.4    Gilmore, R.D.5    Mamula, M.6    Fikrig, E.7
  • 18
    • 61449110987 scopus 로고    scopus 로고
    • Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection
    • Coutte L, Botkin DJ, Gao L, Norris SJ. 2009. Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog 5:e1000293. http://dx.doi.org/10.1371/journal.ppat.1000293.
    • (2009) PLoS Pathog , vol.5
    • Coutte, L.1    Botkin, D.J.2    Gao, L.3    Norris, S.J.4
  • 19
    • 84855900042 scopus 로고    scopus 로고
    • Of ticks, mice and men: Understanding the dual-host lifestyle of Lyme disease spirochaetes
    • Radolf JD, Caimano MJ, Stevenson B, Hu LT. 2012. Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87-99. http://dx.doi.org/10.1038/nrmicro2714.
    • (2012) Nat Rev Microbiol , vol.10 , pp. 87-99
    • Radolf, J.D.1    Caimano, M.J.2    Stevenson, B.3    Hu, L.T.4
  • 20
    • 77649174212 scopus 로고    scopus 로고
    • Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli
    • Dorr T, Vulic M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8:e1000317. http://dx.doi.org/10.1371/journal.pbio.1000317.
    • (2010) PLoS Biol , vol.8
    • Dorr, T.1    Vulic, M.2    Lewis, K.3
  • 21
    • 84886290812 scopus 로고    scopus 로고
    • Molecular mechanism of bacterial persistence by HipA
    • Germain E, Castro-Roa D, Zenkin N, Gerdes K. 2013. Molecular mechanism of bacterial persistence by HipA. Mol Cell 52:248-254. http://dx.doi.org/10.1016/j.molcel.2013.08.045.
    • (2013) Mol Cell , vol.52 , pp. 248-254
    • Germain, E.1    Castro-Roa, D.2    Zenkin, N.3    Gerdes, K.4
  • 23
    • 80054759036 scopus 로고    scopus 로고
    • Regulation of growth and death in Escherichia coli by toxin-antitoxin systems
    • Yamaguchi Y, Inouye M. 2011. Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat Rev Microbiol 9:779-790. http://dx.doi.org/10.1038/nrmicro2651.
    • (2011) Nat Rev Microbiol , vol.9 , pp. 779-790
    • Yamaguchi, Y.1    Inouye, M.2
  • 24
    • 84897904160 scopus 로고    scopus 로고
    • Multiple toxin-antitoxin systems in Mycobacterium tuberculosis
    • Sala A, Bordes P, Genevaux P. 2014. Multiple toxin-antitoxin systems in Mycobacterium tuberculosis. Toxins (Basel) 6:1002-1020. http://dx.doi.org/10.3390/toxins6031002.
    • (2014) Toxins (Basel) , vol.6 , pp. 1002-1020
    • Sala, A.1    Bordes, P.2    Genevaux, P.3
  • 25
    • 14244266086 scopus 로고    scopus 로고
    • Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes
    • Pandey DP, Gerdes K. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res 33:966-976. http://dx.doi.org/10.1093/nar/gki201.
    • (2005) Nucleic Acids Res , vol.33 , pp. 966-976
    • Pandey, D.P.1    Gerdes, K.2
  • 26
    • 0034610332 scopus 로고    scopus 로고
    • Correlation between plasmid content and infectivity in Borrelia burgdorferi
    • Purser JE, Norris SJ. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A 97:13865-13870. http://dx.doi.org/10.1073/pnas.97.25.13865.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 13865-13870
    • Purser, J.E.1    Norris, S.J.2
  • 27
    • 0029200874 scopus 로고
    • Electrotransformation of the spirochete Borrelia burgdorferi
    • Samuels DS. 1995. Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol Biol 47:253-259.
    • (1995) Methods Mol Biol , vol.47 , pp. 253-259
    • Samuels, D.S.1
  • 28
    • 0026658194 scopus 로고
    • In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: A microdilution MIC method and time-kill studies
    • Dever LL, Jorgensen JH, Barbour AG. 1992. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol 30:2692-2697.
    • (1992) J Clin Microbiol , vol.30 , pp. 2692-2697
    • Dever, L.L.1    Jorgensen, J.H.2    Barbour, A.G.3
  • 29
    • 33845607284 scopus 로고    scopus 로고
    • Persister cells, dormancy and infectious disease
    • Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48-56. http://dx.doi.org/10.1038/nrmicro1557.
    • (2007) Nat Rev Microbiol , vol.5 , pp. 48-56
    • Lewis, K.1
  • 30
    • 84899505083 scopus 로고    scopus 로고
    • Molecular mechanisms underlying bacterial persisters
    • Maisonneuve E, Gerdes K. 2014. Molecular mechanisms underlying bacterial persisters. Cell 157:539-548. http://dx.doi.org/10.1016/j.cell.2014.02.050.
    • (2014) Cell , vol.157 , pp. 539-548
    • Maisonneuve, E.1    Gerdes, K.2
  • 31
    • 84908227247 scopus 로고    scopus 로고
    • Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease
    • Conlon BP. 2014. Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease. Bioessays 36:991-996. http://dx.doi.org/10.1002/bies.201400080.
    • (2014) Bioessays , vol.36 , pp. 991-996
    • Conlon, B.P.1
  • 32
    • 84855195248 scopus 로고    scopus 로고
    • Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters
    • Keren I, Minami S, Rubin E, Lewis K. 2011. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2:e00100-11. http://dx.doi.org/10.1128/mBio.00100-11.
    • (2011) mBio , vol.2 , pp. e00100-e00111
    • Keren, I.1    Minami, S.2    Rubin, E.3    Lewis, K.4
  • 33
    • 84868113986 scopus 로고    scopus 로고
    • Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli
    • Norton JP, Mulvey MA. 2012. Toxin-antitoxin systems are important for niche-specific colonization and stress resistance of uropathogenic Escherichia coli. PLoS Pathog 8:e1002954. http://dx.doi.org/10.1371/journal.ppat.1002954.
    • (2012) PLoS Pathog , vol.8
    • Norton, J.P.1    Mulvey, M.A.2
  • 34
    • 0022652442 scopus 로고
    • The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth
    • Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A. 1986. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 132:1297-1304.
    • (1986) J Gen Microbiol , vol.132 , pp. 1297-1304
    • Tuomanen, E.1    Cozens, R.2    Tosch, W.3    Zak, O.4    Tomasz, A.5
  • 35
    • 0016695151 scopus 로고
    • Principles of combination therapy
    • Levin S, Harris AA. 1975. Principles of combination therapy. Bull N Y Acad Med 51:1020-1038.
    • (1975) Bull N Y Acad Med , vol.51 , pp. 1020-1038
    • Levin, S.1    Harris, A.A.2
  • 36
    • 0035173818 scopus 로고    scopus 로고
    • Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials
    • Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183:6746-6751. http://dx.doi.org/10.1128/JB.183.23.6746-6751.2001.
    • (2001) J Bacteriol , vol.183 , pp. 6746-6751
    • Spoering, A.L.1    Lewis, K.2
  • 37
    • 0346492817 scopus 로고    scopus 로고
    • Persister cells and tolerance to antimicrobials
    • Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230:13-18. http://dx.doi.org/10.1016/S0378-1097(03)00856-5.
    • (2004) FEMS Microbiol Lett , vol.230 , pp. 13-18
    • Keren, I.1    Kaldalu, N.2    Spoering, A.3    Wang, Y.4    Lewis, K.5
  • 38
    • 0035050988 scopus 로고    scopus 로고
    • Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose
    • Gee T, Andrews JM, Ashby JP, Marshall G, Wise R. 2001. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose. J Antimicrob Chemother 47:431-434. http://dx.doi.org/10.1093/jac/47.4.431.
    • (2001) J Antimicrob Chemother , vol.47 , pp. 431-434
    • Gee, T.1    Andrews, J.M.2    Ashby, J.P.3    Marshall, G.4    Wise, R.5
  • 39
    • 0033950440 scopus 로고    scopus 로고
    • New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances
    • Hunfeld KP, Kraiczy P, Wichelhaus TA, Schafer V, Brade V. 2000. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances. Eur J Clin Microbiol Infect Dis 19:27-32. http://dx.doi.org/10.1007/s100960050005.
    • (2000) Eur J Clin Microbiol Infect Dis , vol.19 , pp. 27-32
    • Hunfeld, K.P.1    Kraiczy, P.2    Wichelhaus, T.A.3    Schafer, V.4    Brade, V.5
  • 43
    • 84903757348 scopus 로고    scopus 로고
    • Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
    • Feng J, Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. 2014. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect 3:e49. http://dx.doi.org/10.1038/emi.2014.53.
    • (2014) Emerg Microbes Infect , vol.3 , pp. e49
    • Feng, J.1    Wang, T.2    Shi, W.3    Zhang, S.4    Sullivan, D.5    Auwaerter, P.G.6    Zhang, Y.7
  • 46
    • 0035811261 scopus 로고    scopus 로고
    • Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination
    • Keller KL, Overbeck-Carrick TL, Beck DJ. 2001. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination. Mutat Res 486:21-29. http://dx.doi.org/10.1016/S0921-8777(01)00077-5.
    • (2001) Mutat Res , vol.486 , pp. 21-29
    • Keller, K.L.1    Overbeck-Carrick, T.L.2    Beck, D.J.3
  • 49
    • 42949083634 scopus 로고    scopus 로고
    • Chronic Lyme disease: A review
    • Marques A. 2008. Chronic Lyme disease: a review. Infect Dis Clin North Am 22:341-360. http://dx.doi.org/10.1016/j.idc.2007.12.011.
    • (2008) Infect Dis Clin North Am , vol.22 , pp. 341-360
    • Marques, A.1
  • 50
    • 61349183785 scopus 로고    scopus 로고
    • Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis
    • Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE, III, Blanchard JS. 2009. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science 323:1215-1218. http://dx.doi.org/10.1126/science.1167498.
    • (2009) Science , vol.323 , pp. 1215-1218
    • Hugonnet, J.E.1    Tremblay, L.W.2    Boshoff, H.I.3    Barry, C.E.4    Blanchard, J.S.5
  • 51
    • 84874074445 scopus 로고    scopus 로고
    • Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability
    • Iyer R, Mukherjee P, Wang K, Simons J, Wormser GP, Schwartz I. 2013. Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol 51:857-862. http://dx.doi.org/10.1128/JCM.02785-12.
    • (2013) J Clin Microbiol , vol.51 , pp. 857-862
    • Iyer, R.1    Mukherjee, P.2    Wang, K.3    Simons, J.4    Wormser, G.P.5    Schwartz, I.6
  • 52
    • 0036120133 scopus 로고    scopus 로고
    • Role of aminoglycosides in the treatment of bacterial endocarditis
    • Graham JC, Gould FK. 2002. Role of aminoglycosides in the treatment of bacterial endocarditis. J Antimicrob Chemother 49:437-444. http://dx.doi.org/10.1093/jac/49.3.437.
    • (2002) J Antimicrob Chemother , vol.49 , pp. 437-444
    • Graham, J.C.1    Gould, F.K.2
  • 53
    • 50349141358 scopus 로고
    • Treatment of staphylococcal infections with penicillin
    • Bigger JW. 1944. Treatment of staphylococcal infections with penicillin. Lancet 244:497-500.
    • (1944) Lancet , vol.244 , pp. 497-500
    • Bigger, J.W.1
  • 54
    • 84883342218 scopus 로고    scopus 로고
    • (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity
    • Maisonneuve E, Castro-Camargo M, Gerdes K. 2013. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154:1140-1150. http://dx.doi.org/10.1016/j.cell.2013.07.048.
    • (2013) Cell , vol.154 , pp. 1140-1150
    • Maisonneuve, E.1    Castro-Camargo, M.2    Gerdes, K.3
  • 55
    • 33745904995 scopus 로고    scopus 로고
    • GlpD and PlsB participate in persister cell formation in Escherichia coli
    • Spoering AL, Vulic M, Lewis K. 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 188:5136-5144. http://dx.doi.org/10.1128/JB.00369-06.
    • (2006) J Bacteriol , vol.188 , pp. 5136-5144
    • Spoering, A.L.1    Vulic, M.2    Lewis, K.3
  • 56
    • 48749089081 scopus 로고    scopus 로고
    • Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli
    • Hansen S, Lewis K, Vulic M. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52:2718-2726. http://dx.doi.org/10.1128/AAC.00144-08.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2718-2726
    • Hansen, S.1    Lewis, K.2    Vulic, M.3
  • 57
    • 0015347353 scopus 로고
    • Comparative clinical pharmacology of amoxicillin and ampicillin administered orally
    • Gordon C, Regamey C, Kirby WM. 1972. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother 1:504-507. http://dx.doi.org/10.1128/AAC.1.6.504.
    • (1972) Antimicrob Agents Chemother , vol.1 , pp. 504-507
    • Gordon, C.1    Regamey, C.2    Kirby, W.M.3
  • 59
    • 33748057491 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
    • Agwuh KN, MacGowan A. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58:256-265. http://dx.doi.org/10.1093/jac/dkl224.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 256-265
    • Agwuh, K.N.1    MacGowan, A.2
  • 60
    • 0037378761 scopus 로고    scopus 로고
    • Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
    • Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. 2003. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47:1318-1323. http://dx.doi.org/10.1128/AAC.47.4.1318-1323.2003.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 1318-1323
    • Dvorchik, B.H.1    Brazier, D.2    DeBruin, M.F.3    Arbeit, R.D.4
  • 61
    • 29244442296 scopus 로고    scopus 로고
    • The pharmacokinetic and pharmacodynamic properties of vancomycin
    • Rybak MJ. 2006. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42(Suppl):S35-S39. http://dx.doi.org/10.1086/491712.
    • (2006) Clin Infect Dis , vol.42 , pp. S35-S39
    • Rybak, M.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.